I. The impact of complications and comorbidities? What is certain is that older patients have a worse prognosis for idiopathic pulmonary fibrosis than younger patients. There are several possible explanations for this, including the more aggressive course of the disease in the elderly, the time bias with or without diagnostic delay and the severe impact of complications of idiopathic pulmonary fibrosis in the elderly. The wide variety of comorbidities and complications can have a profound impact on quality of life as well as outcomes, especially in older patients. Emphysema syndrome has been reported in close to 1/3 of patients with idiopathic pulmonary fibrosis. An important clue suggests that emphysema syndrome manifests itself as a significant reduction in carbon monoxide diffusion or a modest reduction in lung volume under normal conditions, a phenomenon that results from compensatory effects on the limiting and obstructive processes of pulmonary mechanical function. In idiopathic pulmonary fibrosis, it is not clear whether older patients are more susceptible to emphysema syndrome than younger patients; however, it is likely that: older patients with a history of slow-onset lung disease may result in an underdiagnosis of emphysema syndrome because the examination is dictated by a CT scan of the chest, and patients with a definite diagnosis of slow-onset lung are the least likely to show it on CT. Emphysema syndrome is often associated with pulmonary hypertension, which may be associated with a poorer prognosis for idiopathic pulmonary fibrosis. However, idiopathic pulmonary fibrosis does merit consideration in patients preferentially diagnosed with slow-onset obstructive pulmonary disease and in patients with progressive dyspnea with basal wet rales, as these patients may be treated with antifibrotic therapy or other treatments. Pulmonary hypertension is another common complication in the course of idiopathic pulmonary fibrosis that can result in a poorer prognosis for the disease. However, there are no data showing a higher incidence of pulmonary hypertension in older patients than in younger patients in the idiopathic pulmonary fibrosis population. It is likely that older patients are more susceptible to co-morbidities that contribute to the progression of pulmonary hypertension, including heart failure, coronary heart disease, thrombotic disease, and obstructive sleep apnea. The development of coronary heart disease is an independent risk factor for death in idiopathic pulmonary fibrosis. This correlation was confirmed in the post-lung transplant evaluation of young patients with idiopathic pulmonary fibrosis. At the same time, the association between coronary heart disease and idiopathic pulmonary fibrosis is likely to be even stronger because of the increasing trend in the incidence of coronary heart disease in the elderly population. Obstructive sleep apnea has a high prevalence in people with idiopathic pulmonary fibrosis and is more prevalent in the elderly population; in addition, obstructive sleep apnea is associated with other coexisting conditions of idiopathic pulmonary fibrosis (e.g., gastroesophageal reflux disease, pulmonary hypertension, and coronary heart disease). Sleep obstructive breathing is likely to have a cascade response to these coexisting conditions, such as developing or worsening coronary heart disease, pulmonary hypertension, and gastroesophageal reflux disease. Gastroesophageal reflux disease is not only prevalent in the elderly but also has a high incidence in patients with idiopathic pulmonary fibrosis. The presence of microaspiratory GERD plays an important role in the development of acute worsening of idiopathic pulmonary fibrosis disease. However, patients with idiopathic pulmonary fibrosis generally do not exhibit symptoms of gastroesophageal shunt, and only 47% of patients with significant gastroesophageal reflux were found in a study using acid-base testing. Although the role of gastroesophageal reflux in the onset and course of idiopathic pulmonary fibrosis is unclear, some studies suggest that gastroesophageal reflux has an impact on lung function as well as survival. II. What are the main considerations and challenges in managing the disease in the elderly? Once the diagnosis of idiopathic pulmonary fibrosis is clarified, optimal management can balance the standard measures of patient care with the patient’s hopes, desires, and expectations. The most common approach to continuous monitoring of a patient’s health status is to have the patient reviewed every 3-6 months. At each review, pulmonary function, 6-minute walk test (6MWT), and walking oxygen titration should be considered. However, clinical examinations should be adjusted based on the validity of the information obtained, regardless of whether treatment management is influenced by these results. Ongoing therapeutic management should include prognostic counseling; therefore, the results of a series of physiologic tests will provide a platform for achieving a transition from disease-oriented to palliative measures including end-of-life discussions. In addition, the description of pulmonary function tests (especially 6MWT) needs to be included in the context of other coexisting conditions. 6MWT will be ineffective in the elderly population with pace-limited musculoskeletal disease or significant sarcopenia. The importance of supportive measures in elderly patients with idiopathic pulmonary fibrosis cannot be overlooked. The thresholds for oxygen therapy in older patients with idiopathic pulmonary fibrosis should be the same as those for younger patients, but the delivery system needs to be balanced based on what the older person can tolerate, and their walking needs to be done with the recommended devices. Pulmonary disease rehabilitation is an important management measure for patients of any age with idiopathic pulmonary fibrosis, and it will improve the long-term prognosis of the patient. Although the ability of older patients to participate in and complete pulmonary rehabilitation is limited by a variety of coexisting conditions, regular exercise and activity is essential to maintain functional status. In addition, it is important to include instructions for managing the rehabilitation process of daily activities and performing respiratory training. Comorbidities that can cause shortness of breath should be noted. These comorbidities (e.g., coronary heart disease and congestive heart failure) should be treated carefully to slow shortness of breath and improve quality of life.